1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35421
Full metadata record
DC FieldValueLanguage
dc.contributor.authorReynolds, Gemma K-
dc.contributor.authorMaclean, Marsali-
dc.contributor.authorCliff, Edward R Scheffer-
dc.contributor.authorTeh, Benjamin W-
dc.contributor.authorThursky, Karin A-
dc.contributor.authorSlavin, Monica A-
dc.contributor.authorAnderson, Mary Ann-
dc.contributor.authorHawkes, Eliza A-
dc.date.accessioned2024-09-10T01:01:25Z-
dc.date.available2024-09-10T01:01:25Z-
dc.date.issued2024-07-09-
dc.identifier.citationBlood Advances 2024-07-09; 8(13)en_US
dc.identifier.issn2473-9537-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35421-
dc.language.isoeng-
dc.titleInfections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleBlood Advancesen_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationClinical Hematologyen_US
dc.identifier.affiliationProgram on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA.;Harvard Medical School, Boston, MA.en_US
dc.identifier.affiliationDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen_US
dc.identifier.doi10.1182/bloodadvances.2024012916en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-9561-3592en_US
dc.identifier.orcid0009-0003-1786-4796en_US
dc.identifier.orcid0000-0001-5977-907Xen_US
dc.identifier.orcid0000-0003-0213-5470en_US
dc.identifier.orcid0000-0002-7400-232Xen_US
dc.identifier.orcid0000-0002-8443-314Xen_US
dc.identifier.orcid0000-0002-3515-0215en_US
dc.identifier.orcid0000-0002-0376-2559en_US
dc.identifier.pubmedid38625983-
dc.description.volume8-
dc.description.issue13-
dc.description.startpage3555-
dc.description.endpage3559-
dc.subject.meshtermssecondaryAntibodies, Bispecific/therapeutic use-
dc.subject.meshtermssecondaryAntineoplastic Agents, Immunological/therapeutic use-
dc.subject.meshtermssecondaryAntineoplastic Agents, Immunological/adverse effects-
dc.subject.meshtermssecondaryInfections/etiology-
dc.subject.meshtermssecondaryInfections/drug therapy-
dc.subject.meshtermssecondaryInfections/immunology-
dc.subject.meshtermssecondaryLymphoma/drug therapy-
dc.subject.meshtermssecondaryLymphoma/immunology-
dc.subject.meshtermssecondaryLymphoma/therapy-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

6
checked on Nov 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.